Pyoderma Gangrenosum, Acne Conglobata, Suppurative Hidradenitis, and Axial Spondyloarthritis: Efficacy of Anti-Tumor Necrosis Factor [alpha] Therapy.
ABSTRACT: We report the case of a patient with a simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. This condition differs from both the PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis) syndrome, in which arthritis is...
| Publicado en: | JRC: Journal of Clinical Rheumatology Vol. 18; no. 8; pp. 413 - 416 |
|---|---|
| Autor principal: | |
| Formato: | case study Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
2012 Dec
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108083079&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 108083079 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10761608 N16 jtl: JRC: Journal of Clinical Rheumatology issn: 10761608 maglogo: N pubinfo: dt: 2012 Dec vid: 18 iid: 8 pid: 433 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 108083079 108083079 2011789992 10.1097/RHU.0b013e318278b84c NLM23188209 108083079 ppf: 413 ppct: 3 formats: tig: atl: Pyoderma Gangrenosum, Acne Conglobata, Suppurative Hidradenitis, and Axial Spondyloarthritis: Efficacy of Anti-Tumor Necrosis Factor [alpha] Therapy. aug: au: Bruzzese V affil: From the Internal Medicine and Rheumatology Unit, 'Nuovo Regina Margherita' Hospital, Rome, Italy. sug: subj: Acne Vulgaris Drug Therapy Antiinflammatory Agents, Non-Steroidal Therapeutic Use Antibodies, Monoclonal Therapeutic Use Hidradenitis Suppurativa Drug Therapy Pyoderma Gangrenosum Drug Therapy Spondylarthritis Drug Therapy Acne Vulgaris Complications Adult Blood Sedimentation C-Reactive Protein Analysis Hidradenitis Suppurativa Complications Infusions, Intravenous Isoniazid Therapeutic Use Male Pyoderma Gangrenosum Complications Spondylarthritis Complications Tumor Necrosis Factor Antagonists and Inhibitors Adult: 19-44 years Male ab: ABSTRACT: We report the case of a patient with a simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis. This condition differs from both the PASH (pyoderma gangrenosum, acne, and suppurative hidradenitis) syndrome, in which arthritis is absent, and the PAPA (pyogenic arthritis, pyoderma gangrenosum, and acne) syndrome, in which suppurative hidradenitis is lacking. Our patient failed to respond to etanercept therapy, whereas all dermatologic and rheumatic manifestations completely regressed following infliximab infusion. We therefore propose that simultaneous presence of pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and seronegative spondyloarthritis might represent a distinct syndrome that could be termed the PASS syndrome. Tumor necrosis factor [alpha] therapies seem to play selective roles. pubtype: Academic Journal doctype: case study Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|